|From CAR's partner VEC's results this morning - looks like the VR315 programme continues to go well:
"VR315 (US), (fluticasone propionate/salmeterol), is the Group's partnered programme with Hikma for a generic version of Advair® Diskus® for the treatment of asthma and COPD in adolescents and adults for the US. In April 2016, the US Food and Drug Administration (FDA) accepted an Abbreviated New Drug Application (ANDA) filing made by Hikma and Vectura recognised a milestone receipt of $10 million. The FDA has provided Hikma with a GDUFA goal date of 10 May 2017. Vectura will receive $11 million on approval of the file plus a mid-teen percentage royalty on net sales of VR315 in the US.
This programme remains under FDA regulatory review and we continue to work closely with Hikma through this process. VR315 is one of only two generic Advair® Diskus® ANDAs publicly filed and accepted."|
|Dates for year end trading updates for last 3 years have been as follows -
Shouldn't therefore have long to wait for this year's update and seems to be off the radar for the moment. Imo it's on a nice support level now and I'd be topping up if I didn't already have my full quota.|
|Well it seems some broker is taking the sells as they come in,hold them and are now passing them on to Henderson,can't be bad for lth's down the line..gla lth's|
|Henderson; largest shareholder now....|
|RNS - Hendersons are in a hurry to buy shares. Last month they bought 1.25m sharers to go above 12%, and now they've bought another 300,000 shares to go above 13% with 9.55m shares in total:
Many thanks for that,I did read that piece somewhere sometime,but wonder if from before I bought in had I missed something important re. Vauxhall and the smaller end of the markets,but many thanks again...|
|I think CAR only handle high-end premium.|
|I am saying this out of ignorance,but could the Vauxhall sell to Pergeot, cause any lose of sales,ie.do they supply led's for their headlamps?? tia|
|Peel Hunt today reiterated their Buy and 190p price target:
|really strange todays trading,
just after the start we were unchanged at a 2k sell,then at close with being down just 3k of sells more than buys,we lost 6p or just over 4% of our market cap.
We really got shafted today all right,I see a couple of self rolls going by, and perhaps Instis,taking on the 10k buy also the 7.5 buy and the other high figure of 10767...it's my thoughts,unless someone can pop up and shoot me down..imho...gla|
|Bouncing nicely - the real price now is 132.25p (130p-134.5p spread). No doubt the thread header chart will correct itself when an AT trade goes through.
This was just an MM tactic to drop the price after a few small sells on a small day in a reasonably illiquid stock. A good opportunity for some to pick up cheap stock imho.|
|ok thanks - it'll be interesting to see if the current Offer price of 130p attracts buyers since it dipped to this price just ahead of last month's update|
|No idea why this morning as opposed to any other morning, but if you read back my posts you'll see there is a case to be other than bullish. No idea if it's the right case, but it's plausible. I really didn't like the last analyst slide presentation much. At core, CTP is a very sub critical mass business selling to companies who prefer larger suppliers, for all sorts of perfectly good reasons. (For some reason I still don't understand they bought a sub critical mass supplier too.)|
|Pretty small beer though - only 67k shares traded. Might even be an institutional tactic, i.e sell a few knowing that this is an illiquid stock to get the price down, then load up before the year end trading update at the lower prices.
Certainly seems illogical given the strong trading update only last month.|
|Pretty consistent selling here this morning. Can anyone shed a light as to what might have prompted it?|
|OT : nice plug for SCE Pugugly (from a fellow SCE holder...) :o)) To clarify, if Adrian Newey chooses your products you must be the best in your field.|
|and he chose SCE carbon ceramic brakes - we know they are the best.|
|Carclo is at that 140p level where a breakthrough will signal much better things to come: here's hoping! :) and keep on buying ...|
A slowly moving share,as for many not exciting enough, and they exit to join the adrenaline rush of WEB or GWMO this morning,
I hold all 3 so not bothered,
I like the slowly slowly catch a monkey type myself...|
|Here's the awesome new Aston Martin hypercar just unveiled in public for the first time - CAR's Wipac are named as supplier of all the LED headlights and taillights:
The car is designed by Adrian Newey, the legendary Formula One engineer - if he wanted Wipac's products you can be sure that they're the best.|
|Just be careful of the pension liabilities.
|CAR have just been tipped as "stunning value":
"A steady stream of contract successes from the automotive sector looks set to keep earnings at Carclo (LSE: CAR) surging in the years ahead, in my opinion — here’s why!
Carclo advised last month that at its LED Technologies arm, its Wipac supercar lighting products keep on making a huge impact with the world’s car manufacturers, with the business noting that the segment “continues to win new lighting programmes within the low volume sector”.
And Carclo added that it “remains focused on securing a further mid volume programme in the new financial year, which will support the anticipated strong growth of this business”.
But the huge potential riches afforded by the fast-growing premium and supercar segments are not the only reasons to get excited about. Carclo’s Technical Products division is also gaining momentum, helped by shrewd bolt-on buys like Precision Tool & Die in October. And the West Yorkshire business is looking to ride this wave by turbocharging its manufacturing capacity in China and India.
The City expects Carclo to keep its record of double-digit earnings rises trucking long into the future, and predict a 13% rise in the year to March 2017 to be followed by increases of 13% and 21% in fiscal 2018 and 2019 correspondingly.
And these projections make the engineer stunning value for money, in my mind. For the current period Carclo deals on a P/E ratio of just 12 times, and the multiple topples to a mere 10.6 times for next year and 8.8 times for 2019.
Furthermore, sub-1 PEG multiples through to the close of 2019 illustrate Carclo’s stunning value relative to its growth prospects."|
|great stuff illis. Agree with pension fund - when the market wants to ignore the pension fund it is extremely good at that. Burned myself often on that over the years.
CTP sales were £70 last full year x 1.26 = $88 so yes not way under, nudging or at depending on exchange rate and growth.
Glad you saw some of the same things in the CTP presentation, reassuring.
10% margins not impossible, just a refrain I've got bored of, but that doesn't mean they can't get there. But on the sales per emp in UK and US they'd be doing well to get beyond.
Still confused on PTD this end. Will look again, but I've looked twice and both times found no existing overlap between their output and CTP's output, but may be being thick.
|Further to my blog 309, CAR is slowly but surely getting into a new uptrend, which will show more when the 140p resistance level has been broken through, and become support. I'm tempted to add, but don't want to unbalance my overall portfolio; though a few more would be ok, I guess. For others, I say buy or add now before the price jumps that much higher, which it will before long, IMHO.|
|RNS - Henderson have significantly increased their holding, buying another 1.25m shares or so. They now have 9.24m shares, or 12.66%: